Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentrix (CNXC) Amortization of Deferred Charges (2023 - 2025)

Historic Amortization of Deferred Charges for Concentrix (CNXC) over the last 3 years, with Q4 2025 value amounting to $4.5 million.

  • Concentrix's Amortization of Deferred Charges fell 2633.65% to $4.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $23.5 million, marking a year-over-year decrease of 683.65%. This contributed to the annual value of $23.5 million for FY2025, which is 683.65% down from last year.
  • Per Concentrix's latest filing, its Amortization of Deferred Charges stood at $4.5 million for Q4 2025, which was down 2633.65% from $6.4 million recorded in Q3 2025.
  • In the past 5 years, Concentrix's Amortization of Deferred Charges registered a high of $7.2 million during Q2 2024, and its lowest value of -$5.8 million during Q3 2023.
  • Its 3-year average for Amortization of Deferred Charges is $4.7 million, with a median of $6.1 million in 2024.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first soared by 21000.0% in 2024, then tumbled by 2633.65% in 2025.
  • Concentrix's Amortization of Deferred Charges (Quarter) stood at $4.4 million in 2023, then soared by 38.37% to $6.1 million in 2024, then dropped by 26.34% to $4.5 million in 2025.
  • Its last three reported values are $4.5 million in Q4 2025, $6.4 million for Q3 2025, and $6.6 million during Q2 2025.